For instance, in bladder cancer, transcriptomic analysis of 200 patients and five normal samples revealed IGFBP-5 as a tumor sensitivity predictor of anti-IGF therapy that inversely corelated with IGF phosphorylation pathways [89]. Here, IGF1 is linked to neoplasm.